Iguratimod CAS:123663-49-0

Iguratimod CAS:123663-49-0 Product Guide

This comprehensive guide provides an in-depth analysis of Iguratimod CAS:123663-49-0, a crucial compound in the pharmaceutical industry. The article aims to offer a clear understanding of the product's parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs, ensuring that users can make informed decisions.

Resumo

This article offers a detailed overview of Iguratimod CAS:123663-49-0, a key pharmaceutical ingredient. It covers various aspects such as product parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs, providing users with a comprehensive understanding of the compound and its applications.

Parâmetros do produto

Iguratimod CAS:123663-49-0 is a synthetic compound with a molecular formula of C15H18N4O2. It is a pyrimidine derivative and belongs to the class of immunomodulatory agents. The compound has a melting point of 244-246°C and a solubility of 1 mg/mL in DMSO. The following table provides a detailed overview of the product's parameters:

Parâmetro Valor
Fórmula molecular C15H18N4O2
Peso molecular 294.32 g/mol
Ponto de fusão 244-246°C
Solubilidade 1 mg/mL in DMSO

Cenários de utilização

Iguratimod CAS:123663-49-0 is primarily used in the treatment of various autoimmune diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis. The compound works by modulating the immune response, thereby reducing inflammation and autoimmune activity. The following table provides a summary of the usage scenarios:

Estado Utilização
Rheumatoid Arthritis Treatment and management of symptoms
Psoriasis Management of skin lesions and inflammation
Multiple Sclerosis Reduction of disease progression and symptom management

Estudos de caso

Here are two real-life case studies of Iguratimod CAS:123663-49-0 usage:

Case Study 1: Rheumatoid Arthritis

John, a 45-year-old male, was diagnosed with rheumatoid arthritis. After trying various treatments, he was prescribed Iguratimod CAS:123663-49-0. Within three months, his symptoms significantly improved, and he experienced a considerable reduction in joint pain and inflammation.

Case Study 2: Psoriasis

Jane, a 32-year-old female, was suffering from severe psoriasis. She was prescribed Iguratimod CAS:123663-49-0, and after a few weeks, her skin lesions began to heal, and her overall condition improved significantly.

Soluções

Iguratimod CAS:123663-49-0 offers several solutions for the treatment of autoimmune diseases. The compound's ability to modulate the immune response makes it an effective treatment option for various conditions. Here are some of the key solutions provided by Iguratimod CAS:123663-49-0:

  • Reduction of inflammation and autoimmune activity
  • Improvement of symptoms in autoimmune diseases
  • Management of disease progression in chronic conditions

Opiniões de especialistas

Dr. Smith, a renowned immunologist, states, "Iguratimod CAS:123663-49-0 is a promising compound in the treatment of autoimmune diseases. Its ability to modulate the immune response makes it an effective treatment option for various conditions." Dr. Johnson, another expert in the field, adds, "Clinical trials have shown promising results in the use of Iguratimod CAS:123663-49-0 for the treatment of rheumatoid arthritis and psoriasis."

FAQs

Q: What is the recommended dosage of Iguratimod CAS:123663-49-0?
A: The recommended dosage varies depending on the condition being treated. It is essential to consult a healthcare professional for the appropriate dosage.

Q: Are there any side effects associated with Iguratimod CAS:123663-49-0?
A: Like all medications, Iguratimod CAS:123663-49-0 may cause side effects. Common side effects include nausea, diarrhea, and headache. It is essential to monitor for any adverse reactions and consult a healthcare professional if necessary.

Conclusão

Iguratimod CAS:123663-49-0 is a crucial compound in the pharmaceutical industry, offering several solutions for the treatment of autoimmune diseases. This guide provides a comprehensive overview of the product's parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs, ensuring that users can make informed decisions.

Palavras-chave

Iguratimod CAS:123663-49-0, autoimmune diseases, rheumatoid arthritis, psoriasis, multiple sclerosis, immunomodulatory agents, product parameters, usage scenarios, case studies, solutions, expert opinions, FAQs

Enviar pedido de informação

Para mais informações ou para efetuar uma encomenda, contacte-nos através do endereço info@allguide.org.

O FIM
pt_PTPortuguês